Patients

Ballad Well being’s program for aiding uninsured sufferers earns nationwide award for its community-based strategy to serving rural Appalachia
Press Releases

Ballad Well being’s program for aiding uninsured sufferers earns nationwide award for its community-based strategy to serving rural Appalachia

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Significant Efficacy in Sufferers with HER2-Expressing, Recurrent Endometrial Most cancers
Press Releases

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Significant Efficacy in Sufferers with HER2-Expressing, Recurrent Endometrial Most cancers

Regeneron Collaborates with TriNetX to Entry De-Recognized Digital Well being Data of 300 Million Sufferers to Drive Analysis and Product Growth in Life Sciences and Digital Well being Options
Partnerships

Regeneron Collaborates with TriNetX to Entry De-Recognized Digital Well being Data of 300 Million Sufferers to Drive Analysis and Product Growth in Life Sciences and Digital Well being Options

Pharming Group publicizes approval of Joenja® (leniolisib) in Japan for the therapy of APDS in sufferers aged 4 years and older
Press Releases

Pharming Group publicizes approval of Joenja® (leniolisib) in Japan for the therapy of APDS in sufferers aged 4 years and older

Rhythm Prescribed drugs Publicizes FDA Approval of IMCIVREE® (setmelanotide) for Sufferers with Acquired Hypothalamic Weight problems
Product / Services

Rhythm Prescribed drugs Publicizes FDA Approval of IMCIVREE® (setmelanotide) for Sufferers with Acquired Hypothalamic Weight problems